anonymous
Guest
anonymous
Guest
What about the Tralokinumab failure? Does this surprise anyone? What are resp. bio. reps gonna do now?
We are going to sell what we are hired for...selling benralizumab. Troll.What about the Tralokinumab failure? Does this surprise anyone? What are resp. bio. reps gonna do now?
December 14th is the day! Entire Respitory division will be displaced. Joining 1000 CVMD HQ and field based personnel. HSS will also be cut and then some will be folded into vacancies.
We are going to sell what we are hired for...selling benralizumab. Troll.
Watch on Thursday, Q3 earnings reported. This will be a fairly good indicator of layoffs. And if the enterprise years are finished
Watch on Thursday, Q3 earnings reported. This will be a fairly good indicator of layoffs. And if the enterprise years are finished
Come on it is way too early in the year to talk about layoffs. These wont be announced until the day before Thanksgiving with all employees exited by January 1. Of course we will protect at British employees because they are sooooo special.
this may seem like a crazy thought but how can we be spared from a layoff.? I’m new to pharma and it is alarming how everyone pretends to be busy and yet so very little to do on a daily basis. It seems to me cutting reps Would seem obvious. I want and need my job however thinking this pharma thing is not as great as I thought .
this may seem like a crazy thought but how can we be spared from a layoff.? I’m new to pharma and it is alarming how everyone pretends to be busy and yet so very little to do on a daily basis. It seems to me cutting reps Would seem obvious. I want and need my job however thinking this pharma thing is not as great as I thought .
Just play the game as instructed. No matter what you actual performance is, they will find a way to make you a COE contender. If the 20% driving sales quit, the 80% gaming the system would be forced to perform. The good news for that 80%, there are always displaced or disgruntled reps who could easily backfill any performer. Performers are limited in development opportunity. Five years and out seems to be the trend. The risk of letting performers move up to leadership roles is that the culture swings to a performance based culture and away from a bullshit based culture.